Merilyn Varghese, MD MSc (@MerilynVarghese) profile picture

Cardiologist @Yale | Fellowship @BIDMC | Former Chief Resident @YaleIM_Chiefs

Joined March 2022
Photo by Merilyn Varghese, MD MSc (@MerilynVarghese)Photo by Merilyn Varghese, MD MSc (@MerilynVarghese)Photo by Merilyn Varghese, MD MSc (@MerilynVarghese)
Merilyn Varghese, MD MSc retweeted
CR participation among US Veterans remains low vs Medicare (10.4% vs 28%), with no sig differences in initiation by sex. Lower socioeconomic status is linked to reduced uptake. More research needed. jacc.org/doi/10.1016/j.jacad… #JACCAdvances #cvRehab @MerilynVarghese
2
11
2,331
Merilyn Varghese, MD MSc retweeted
Now in press in @MyJSCAI, our comprehensive review "Evaluating Ischemic Heart Disease in Women: Focus on Angina With Nonobstructive Coronary Arteries (ANOCA)" jscai.org/article/S2772-9303… How should we evaluate women with ischemic heart disease? This our approach @CesiaGallegos @SpatzErica @CigarroaNatasha @edwardmillermd @WHRYale @YaleCardiology @YaleIMed @InocaInternati1 @heart_spasms
1
19
3
44
6,094
Merilyn Varghese, MD MSc retweeted
Replying to @JAMACardio
@JAMACardio We profiled exercise BP using plasma proteomics in search of new HTN/CVD biomarkers. TGFBR3 emerged as a novel marker of exercise SBP & incident HTN across multiple cohorts & platforms, supported by genetic/MR experiments Huge team effort 🙏 bit.ly/4cg5krF
3
11
3
57
8,168
Merilyn Varghese, MD MSc retweeted
.@GeorgeGoshuaMD accepts the prestigious NOMIS and @ScienceMagazine Young Explorer Award in Zurich, Switzerland. Read more about Dr. Goshua and his winning essay "Napkin math can change the world." yalecancercenter.org/news-ar… @SmilowCancer @YaleMed @YNHH @YaleHematology
8
7
28
8,081
Merilyn Varghese, MD MSc retweeted
Now published in @AmJCardio "Real-World Experience and Outcomes With Percutaneous Coronary Intervention for Protected Versus Unprotected Left Main Coronary Artery Disease" Full article: authors.elsevier.com/c/1j5bV… Led by @engelpedro, @DeptVetAffairs, and our team @YaleCardiology
1
5
21
2,075
Merilyn Varghese, MD MSc retweeted
Dr. George Goshua has been appointed to the @AnnalsofIM  Editorial Board for a 3-year term. Read more about @GeorgeGoshuaMD and the role. @YaleHematology @YaleCancer @SmilowCancer  medicine.yale.edu/intmed/new…
2
2
3
33
10,573
Merilyn Varghese, MD MSc retweeted
📢💫@SatokoItoMDPhD = hematologist+palliative care MD+epidemiologist! Her first @YaleCancer @YaleHematology @YaleMed pub @AnnalsofIM in <6 weeks #GoshuaLab Editorial doi.org/10.7326/M22-3404 Potent CEA by👏@ShuchiGulati: all oral-Xa inhibitors v LMWH in CAT doi.org/10.7326/M22-1258
6
7
27
5,688
Merilyn Varghese, MD MSc retweeted
Tonight at 7:30pm on Yale Cancer Answers, join us to learn about the field of classical #hematology and current research initiatives into rare blood disorders with @GeorgeGoshuaMD. Listen live on @wnpr or @iTunes. @YaleHemOnc @YaleHematology @SmilowCancer @YaleMed
1
5
2
25
In our most recent work presented at #AHA22 with simultaneous pub in @CircCQO, we asked: what was the impact of the COVID-19 pandemic on #cardiacrehab (CR) use among Medicare beneficiaries? Link: tinyurl.com/8zdjz5sh Thread: 👇
1
13
2
42
Where do we go from here?🤔 We need significant innovation in CR financing and delivery, and urgently need to think about the use of novel care models, including virtual CR, to expand access and address widening disparities.
1
4
A special thank you to @kardiologykazi for his invaluable mentorship. Thank you to all our collaborators for their guidance, @AlexisLBeatty @gcfmd @kevfromRI @rwyeh @joefigs2, and to @SmithBIDMC @BIDMCVfellows @BidmcCvi and @BIDMChealth for their ongoing support!
1
7
Merilyn Varghese, MD MSc retweeted
Marked declines in #CardiacRehab use since the start of the pandemic. @MerilynVarghese discusses how this may exacerbate disparities in CV outcomes and offers potential solns. 10.15am tomorrow in S104B. Join us! @SmithBIDMC
2
10